An analysis of 117 cancer drugs approved by the US FDA over a 20-year period finds the drugs took a median of 6.5 years to go from the first clinical trial in adults to the first trial in children. 'As a doctor taking care of young cancer patients, this is tremendously frustrating,' says lead researcher Steven DuBois, M.D. 'If I were a parent of a child with cancer, I wouldn't stand for this.'
from EurekAlert! - Breaking News http://bit.ly/2werOqQ
via IFTTT
Wednesday, May 22, 2019
Children with cancer wait an average of 6.5 years longer than adults to access new drugs
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.